Clinical trial · Observational
Quality of Life in Patients With Bladder Cancer
A Prospective Study of Quality of Life in Patients With Bladder Cancer
NCT00745355CI-TRIAL-00113276active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Quality Of Life questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- new patients with bladder cancer and/or are scheduled for radical cystectomy and urinary diversion
- interventionNames
- Behavioral: Quality Of Life questionnaires
Primary outcomes (1)
- measure
- Prospectively characterize the impact of radical cystectomy and different urinary diversions on quality of life of bladder cancer patients.
- timeFrame
- conclusion of study
Secondary outcomes (3)
- measure
- Compare various standard and idiographic measures of QOL, to determine their relative contributions in accounting for variance in key outcome criteria and prediction of patient QOL at subsequent assessment points.
- timeFrame
- conclusion of study
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * All patients (male and female) who are diagnosed with bladder cancer * Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy. * Participants must be able to speak English. * Participants must be able to provide informed consent. * Participants must be 18 years of age or older to enroll. * Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy. * Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon). Exclusion Criteria: * Subjects may be excluded from the study based on the following criteria: * Follow-up care not obtained at MSKCC. * Metastatic disease at diagnosis.
References
Publications (0)
Data not yet available
No reference posted for this study.